Curated News
By: NewsRamp Editorial Staff
November 03, 2026

HeartBeam Sets Q3 2026 Earnings Call, ALIGN-ACS Data in Focus

Discuss on Substack
Original Source

TLDR

  • HeartBeam will update investors on Q3 2026 results and ALIGN-ACS pilot data, offering early insight into its heart attack detection program.
  • HeartBeam will host a conference call on Nov. 12, 2026, to discuss Q3 financials, recent achievements, and upcoming milestones.
  • HeartBeam's cable-free 3D ECG technology aims to detect cardiac conditions outside hospitals, making heart care more accessible and proactive.
  • HeartBeam's portable device collects ECG signals from three directions and synthesizes them into a 12-lead ECG without cables.

Impact - Why it Matters

This earnings call is a critical checkpoint for HeartBeam as it transitions from R&D to commercialization. The ALIGN-ACS pilot study results could validate the company’s 3D ECG technology in a real-world setting, potentially accelerating regulatory clearance and adoption. With FDA clearances already secured for arrhythmia assessment and 12-lead ECG synthesis, positive data and clear milestones for the Heart Attack Detection program could significantly enhance HeartBeam’s market position and investor confidence. For patients, this technology promises faster, more accessible cardiac monitoring outside traditional healthcare settings, which could lead to earlier detection of heart attacks and improved outcomes. The call also provides transparency into the company’s financial health, which is essential for sustaining its innovative pipeline.

Summary

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care, has announced it will host a conference call on Thursday, Nov. 12, 2026, at 4:30 p.m. ET to discuss its financial results for the third quarter ended Sept. 30, 2026. The call will be led by Executive Chairman Richard Ferrari, President and Founder Branislav Vajdic, Ph.D., and Chief Financial Officer Timothy Cruickshank, and will include a question-and-answer session. Management will also provide updates on recent achievements, including results from the ALIGN-ACS pilot study, and upcoming milestones for the company’s Heart Attack Detection program. A press release detailing the quarterly results will be issued before the call. Investors and other interested parties can access the conference by dialing 1-877-704-4453 domestically or 1-201-389-0920 internationally using conference code 13763268. A webcast and accompanying presentation will be available, with a telephone replay accessible approximately three hours after the call through Nov. 26, 2026.

HeartBeam is dedicated to transforming the detection and monitoring of critical cardiac conditions. The company is creating the first-ever cable-free device capable of collecting ECG signals in 3D from three non-coplanar directions and synthesizing them into a 12-lead ECG. This platform technology is designed for portable devices that can be used wherever the patient is, delivering actionable heart intelligence. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to appropriate care—all outside of a medical facility—thus redefining the future of cardiac health management. HeartBeam’s 3D ECG technology received FDA clearance for arrhythmia assessment in December 2024 and for its 12-lead ECG synthesis software in December 2025. The company holds over 20 issued patents related to technology enablement. For more details, refer to the Company’s Cleared Indications for Use at https://www.heartbeam.com/indications.

The announcement is being distributed through MissionIR, a specialized communications platform that assists IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. MissionIR is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers access to a vast network of wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution via IBN to millions of social media followers, and a full array of tailored corporate communications solutions. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness. For more information, please visit www.MissionIR.com.

Source Statement

This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, HeartBeam Sets Q3 2026 Earnings Call, ALIGN-ACS Data in Focus

Blockchain registration record for this content